Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer have?
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer has 197 citations in the OpenAlex counts ScholarIQ stores.
When was Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer published?
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer has 2017 year in the ScholarIQ index.
What is the open-access status of Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer?
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer has closed oa status in the ScholarIQ index.
What is the DOI of Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer?
The DOI for Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer is on the source record.
What is the PMID of Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer?
The PMID for Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer is on the source record.
What is the OpenAlex record for Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer?
The OpenAlex for Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer is on the source record.